What is the ROE (Return on Equity) of Suzuken Co this year?
The ROE of Suzuken Co this year is 0.07 undefined.
Suzuken Co ROE 2024
Suzuken Co ROE
0.07
Ticker
9987.T
ISIN
JP3398000004
WKN
914027
In 2024, Suzuken Co's return on equity (ROE) was 0.07, a 102.27% increase from the 0.03 ROE in the previous year.
Suzuken Co Aktienanalyse
What does Suzuken Co do?
Suzuken Co., Ltd. is a leading provider of health products and services in Japan. The company was founded in 1924 and is headquartered in Nagoya. It started as a small family business and has grown over the years to become one of the largest health companies in the country. Suzuken employs over 12,000 employees and has built a wide network of subsidiaries and partner companies. Its business model is based on three core areas: pharmaceuticals, medical devices, and health services. Suzuken is a major player in the Japanese pharmaceutical market, distributing a wide range of products including generic drugs, anti-allergy products, painkillers, and cold medicines. It specializes in the development and distribution of diagnostic and treatment devices in the medical devices sector. Suzuken is also focused on providing health services to the Japanese population, including health check-ups, diabetes management, rehabilitation, and care. It operates a chain of retail stores offering products such as medication, supplements, and medical devices. Suzuken has expanded its international activities in recent years, establishing subsidiaries and partner companies in China, Taiwan, Singapore, Thailand, and the US. The company aims to become a global leader in health products and services. Suzuken places a strong emphasis on sustainability and social responsibility, promoting environmentally friendly technologies and efficient resource utilization. It also engages in charitable activities and nonprofit projects to improve the health and well-being of the communities in which it operates. In summary, Suzuken is a versatile company with a strong focus on health products and services. It has a long history and is a prominent player in the Japanese health market. With its diverse portfolio of pharmaceuticals, medical products, and health services, Suzuken is well-positioned to respond to the changing needs of both the Japanese and global society. Suzuken Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Suzuken Co's Return on Equity (ROE)
Suzuken Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Suzuken Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Suzuken Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Suzuken Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Suzuken Co stock
How has the Return on Equity (ROE) of Suzuken Co developed compared to the previous year?
The ROE of Suzuken Co has increased by 102.27% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Suzuken Co?
A high ROE indicates that Suzuken Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Suzuken Co?
A low ROE can indicate that Suzuken Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Suzuken Co affect the company?
A change in ROE (Return on Equity) of Suzuken Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Suzuken Co?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Suzuken Co?
Some factors that can influence Suzuken Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Suzuken Co pay?
Over the past 12 months, Suzuken Co paid a dividend of 90 JPY . This corresponds to a dividend yield of about 1.89 %. For the coming 12 months, Suzuken Co is expected to pay a dividend of 91.58 JPY.
What is the dividend yield of Suzuken Co?
The current dividend yield of Suzuken Co is 1.89 %.
When does Suzuken Co pay dividends?
Suzuken Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Suzuken Co?
Suzuken Co paid dividends every year for the past 23 years.
What is the dividend of Suzuken Co?
For the upcoming 12 months, dividends amounting to 91.58 JPY are expected. This corresponds to a dividend yield of 1.92 %.
In which sector is Suzuken Co located?
Suzuken Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Suzuken Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Suzuken Co from 12/1/2024 amounting to 50 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Suzuken Co pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Suzuken Co in the year 2023?
In the year 2023, Suzuken Co distributed 76 JPY as dividends.
In which currency does Suzuken Co pay out the dividend?
The dividends of Suzuken Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Suzuken Co
Our stock analysis for Suzuken Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Suzuken Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
